AnaptysBio
ANAB
$26.35
Share price
1.27%
Change (1 day)
24.47%
Change (1 year)
Categories
P/S ratio for AnaptysBio (ANAB)
P/S ratio as of May 2024 (TTM): 41.4
According to AnaptysBio's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 41.4309. At the end of 2023 the company had a P/S ratio of 33.2.
P/S ratio history for AnaptysBio from 2017 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 33.2 | -61.26% |
| 2022 | 85.7 | 463.26% |
| 2021 | 15.2 | 93.91% |
| 2020 | 7.84 | -85.83% |
| 2019 | 55.4 | -83.88% |
| 2018 | 343 | 43.47% |
| 2017 | 239 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |